CURRENT SITUATION AND BARRIERS TO HPV VACCINATION AMONG FEMALE NURSING STUDENTS AT TRA VINH UNIVERSITY, VIETNAM, 2024

Lam Tai Hoang Hieu 1 , , Ngo Le Hoang Giang 1 , Thach Lan Trinh 1
1 Tra Vinh University image/svg+xml
* Corresponding author:

Article Information

Metrics
Downloads: 9 Views: 29
DOI
10.63947/bvtn.v1i5.17
Published
2025-11-01
Issue Vol. 1 No. 5 (2025): Thong Nhat Hospital’s 50-Year Journey - Comprehensive Healthcare and Healthy Aging
Section
Original Research
Categories
Research

Download Article

PDF

How to Cite

1.
Tai Hoang Hieu L, Le Hoang Giang N, Lan Trinh T. CURRENT SITUATION AND BARRIERS TO HPV VACCINATION AMONG FEMALE NURSING STUDENTS AT TRA VINH UNIVERSITY, VIETNAM, 2024. JHA [Internet]. Vietnam; 2025 Nov. 1 [cited 2025 Nov. 5];1(5):112–116. https://tcsuckhoelaohoa.vn/bvtn/article/view/92 doi: 10.63947/bvtn.v1i5.17
Loading citation...
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Cervical cancer is one of the most common cancers in women and can be prevented through HPV vaccination. However, HPV vaccination coverage in Vietnam remains low, especially among healthcare students. This study aimed to assess the status and barriers to HPV vaccination among female nursing students at Tra Vinh University. A descriptive cross-sectional study was conducted among 233 female nursing students from May to July 2024. Data were collected using a self-administered questionnaire and analyzed with SPSS 22.0, employing descriptive statistics, Chi-square tests, and logistic regression. Only 15.5% of students had received at least one dose of HPV vaccine, with 9.4% completing the full three-dose schedule. The main barriers included high cost (73.4%), concerns about side effects (28.8%), perception of unnecessary vaccination without prior sexual activity (22.3%), and lack of accurate information (21.5%). Most students had good knowledge and positive attitudes: 91.4% knew HPV vaccine prevents cervical cancer, 91.8% trusted its effectiveness, and 92.3% were willing to recommend it to peers. HPV vaccination coverage among female nursing students remains low, largely due to financial constraints and insufficient information. Strengthened health education and financial support policies are essential to improve vaccination uptake in this population.

Keywords

HPV Vaccine Barriers Cervical cancer Nursing students

References

  1. Borlu A, Balci E, Sagiroglu M, Gunay O. Knowledge and attitudes of medical and non-medical Turkish university students about cervical cancer and HPV vaccination. Asian Pac J Cancer Prev. 2016;17(1):288-93. DOI: https://doi.org/10.7314/APJCP.2016.17.1.299
  2. Olaitan A. Updates on HPV vaccination. J Obstet Gynaecol. 2023;13(2):243. DOI: https://doi.org/10.3390/diagnostics13020243
  3. Shetty AK, Prabhu S, Shetty S, Shetty V. Knowledge, attitudes and factors associated with acceptability of human papillomavirus vaccination among undergraduate medical, dental and nursing students in South India. Hum Vaccin Immunother. 2019;15(7-8):1656-65. DOI: https://doi.org/10.1080/21645515.2019.1565260
  4. Gu A, Zhou L, Xu X, Li Y, et al. On imported and domestic human papillomavirus vaccines: cognition, attitude, and willingness to pay in Chinese medical students. Front Public Health. 2022;10:863748. DOI: https://doi.org/10.3389/fpubh.2022.863748
  5. Centers for Disease Control and Prevention. Adult immunization schedule by age. CDC. 2024.
  6. Centers for Disease Control and Prevention. Cervical cancer. CDC. 2023.
  7. Centers for Disease Control and Prevention. Human papillomavirus (HPV) infection. CDC. 2021.
  8. Law CK, Leung JTC. Revisiting knowledge, attitudes and practice (KAP) on human papillomavirus (HPV) vaccination among female university students in Hong Kong. Hum Vaccin Immunother. 2018;14(4):924-30. DOI: https://doi.org/10.1080/21645515.2017.1415685
  9. Pelullo CP, Di Giuseppe G, Esposito MR. Human papillomavirus infection and vaccination: knowledge and attitudes among nursing students in Italy. Int J Environ Res Public Health. 2019;16(10):1770. DOI: https://doi.org/10.3390/ijerph16101770
  10. Global Cancer Observatory. Global cancer statistics. Lyon, France: IARC; 2018.
  11. Global Cancer Observatory. Global cancer statistics. Lyon, France: IARC; 2020.
  12. Global Cancer Observatory. Summary statistics. Lyon, France: IARC; 2020.
  13. Global Cancer Observatory. Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Lyon, France: IARC; 2018.
  14. Hall MT, Lew JB, Smith MA, Simms KT, et al. The projected timeframe until cervical cancer elimination in Australia: a modelling study. Lancet Public Health. 2019;4(1):19-27. DOI: https://doi.org/10.1016/S2468-2667(18)30183-X
  15. Wang J, Zhou L, Cheng P, et al. HPV vaccine hesitancy among medical students in China: a multicenter survey. Front Public Health. 2022;10:774767. DOI: https://doi.org/10.3389/fpubh.2022.774767
  16. Wu J, Zheng L, Zheng M. Barriers to and facilitators of human papillomavirus vaccination among people aged 9 to 26 years: a systematic review. Sex Transm Dis. 2021;48(12):255-62. DOI: https://doi.org/10.1097/OLQ.0000000000001407
  17. Liu Y, et al. Knowledge, practice and attitude towards HPV vaccination among college students in Beijing, China. Hum Vaccin Immunother. 2020;16(1):116-23. DOI: https://doi.org/10.1080/21645515.2019.1638727
  18. National Institutes of Health. Human papillomavirus (HPV). NIH. 2021.
  19. Pimple S, Mishra G. Cancer cervix: epidemiology and disease burden. Cytojournal. 2022;19:29. DOI: https://doi.org/10.25259/CMAS_03_02_2021
  20. Wilailak S, Kehoe S, Kengsakul M. Worldwide initiatives to eliminate cervical cancer. Int J Gynaecol Obstet. 2021;155(S1):102-6. DOI: https://doi.org/10.1002/ijgo.13879
  21. Singh D, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11(2):e197-e206. DOI: https://doi.org/10.1016/S2214-109X(22)00501-0
  22. World Health Organization. Cervical cancer. WHO. 2023.
  23. World Health Organization. Global Advisory Committee on Vaccine Safety, 7–8 June 2017. WHO. 2017.
  24. World Health Organization. Guidelines for screening and treatment of precancerous lesions for cervical cancer prevention. WHO. 2013.
  25. World Health Organization. Human papillomavirus (HPV) vaccines. WHO. 2021.
  26. World Health Organization. Safety of HPV vaccines. WHO. 2017.
  27. World Health Organization. Vaccines and immunization: what is vaccination?. WHO. 2021.

License

© 2025 The Author(s). Published by Journal of Health and Aging.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.